James Mutamba - Profile and Investment Details

Investor Profile

James Mutamba is a Venture Capital based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology, Alnara Pharmaceuticals, Colorescience, Calithera Biosciences, Bicycle Therapeutics, PTC Therapeutics, Flex Pharma, ArcherDX, Johnson & Johnson, Sitryx Therapeutics, KalVista Pharmaceuticals, ImmuneID, XyloCor Therapeutics, Werewolf Therapeutics, ImYoo, Renovia, Grail, Axial Biotherapeutics, Channel MedsystemsIlluminOss Medical, Millendo Therapeutics, Princeton University, Be Biopharma, Twentyeight-Seven Therapeutics, Recros Medica, TScan Therapeutics, Pyxis Oncology, . Over time, James Mutamba has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether James Mutamba is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Rare Diseases, Life Science, Engineering, Bioinformatics, Biotechnology, Drug Development, Precision Medicine, Neuroscience, Licensing, Health Diagnostics, Medical, Information Technology, B2B, Therapeutics, Personal Health, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with James Mutamba, as their portfolio suggests a familiarity and interest in this area.

Understanding James Mutamba’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.